IDH2 and glioma: To address this shortcoming and find alternative therapeutic targets, we began with a multi-omics approach to characterize the multiple effects of the IDH mutation on chromatin structure using two previously published and validated models of IDH glioma: (1) IDH1 mutant over-expression on E12 murine embryonic neurospheres37.